Medinotec Inc (MDNC) Return on Investment ROI from the first quarter of 2026 to first quarter of 2026 and for the year 2026, average high and low, overall ranking from May 31 2026 to May 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Medinotec Inc   (MDNC)


Medinotec Inc's ROI from its first quarter of 2026 to the first quarter of 2026 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Medinotec Inc's ROI in the first quarter of 2026?
Medinotec Inc achieved a return on average invested assets (ROI) of 13.06 % in its first quarter of 2026, which is below Medinotec Inc's average return on investment, which stands at 16.91%.

ROI has improved compared to 12.13% in the fourth quarter of 2026, due to net income growth.

Within the Healthcare sector 82 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 153 to 660.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (May 31 2026)
I. Quarter		 (Feb 28 2026)
IV. Quarter		 (Nov 30 2025)
III. Quarter		 (Aug 31 2025)
II. Quarter		 (May 31 2025)
I. Quarter
Y / Y Investment Change TTM 52.24 % 84.37 % 133.09 % 141.74 % 79.92 %
Y / Y Net Income Change TTM -58.7 % -63.21 % 243.12 % 504.34 % 2406.83 %
Investment (TTM) in Millions 8 7 6 6 6
Return On Investment (TTM) 13.06 % 12.13 % 37.45 % 41.78 % 48.14 %
MDNC's Overall Ranking # 660 # 153 # 116 # 88 # 77
Seq. Investment Change TTM 5.51 % 4.81 % 16.2 % 18.48 % 27.78 %
Seq. Net Income Change TTM 13.62 % -66.06 % 4.14 % 2.83 % 1.23 %
Net Income (TTM) in Millions 1 1 2 2 2

MDNC Company Profile >> Back to MDNC Roi Comparisons >> See Annual MDNC Return On Investment



Return On Investment MDNC's Ranking
Within: No.
Industry # 21
Sector # 83
Overall # 660

Return On Investment Statistics
High Average Low
60.77 %
16.91 %
-14.08 %
(Feb 28 2025)   (Feb 29 2024)







Financial Statements
Medinotec Inc's I. Quarter Investments $ 8 Millions MDNC's Balance sheet
Medinotec Inc's I. Quarter Income $ 0 Millions Quarterly MDNC's Income Statement
MDNC's Income by Division See MDNC's Income by Division


MDNC Annual Return On Investment (Feb 28 2026)
2026		 (Feb 28 2025)
2025		 (Feb 29 2024)
2024		 (Feb 28 2023)
2023
Total Investments in Millions 7 6 3 1 0
Y / Y Investment Growth 19.32 % 127.46 % 200.86 % - -
Net Income in Millions 1 2 0 0 0
Y / Y Net Income Growth -63.21 % - - - -
Annual Return On Investment 10.7 % 34.71 % -14.79 % -38.79 % -


Annual Roi Comment
In the fiscal year 2026 ROI decreased relative to the previous year to 10.7 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
MDNC's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for MDNC's Competitors
Subscribers only: Roi for Medinotec Inc's Suppliers
Subscribers only: Return On Investment for MDNC's Customers

Other Ratios
MDNC's Roa MDNC's Inventory Turnover Ratio MDNC's Growth Rates MDNC's Dividend Statistics
MDNC's Profitability Ratios MDNC's Asset Turnover Ratio MDNC's Dividend Growth
MDNC's Roe MDNC's Valuation Ratios MDNC's Financial Strength Ratios MDNC's Dividend Payout Ratio



Companies with similar Return On Investment at May 31 2026, within Healthcare Sector ROI
Medpace Holdings Inc   35.54 %
Mettler toledo International Inc   34.41 %
Eli Lilly And Company  33.95 %
Acadia Pharmaceuticals Inc   31.05 %
Caredx Inc   29.42 %
Adma Biologics Inc   28.94 %
Protalix Biotherapeutics inc   25.72 %
Pro dex Inc   24.29 %
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %

Date modified: 2026-07-10T05:52:43+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.